Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The long-term outcome of patients with hypertensive cardiomyopathy

Journal of Human Hypertension volume 19, pages 393–400 (2005)Cite this article

Abstract

The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusively due to hypertension. From October 1995 to May 2001, 90 consecutive patients with echocardiographic fractional shortening (FS) <30% and 29 control patients with FS ⩾30% were included. Obstructive coronary disease was excluded by dipyridamole myocardial perfusion imaging in all patients and coronary angiography in 60. After a mean follow-up of 4.3±1.6 years, the total mortality rate of HT-DCM was twice as much higher than that of patients without left ventricular systolic dysfunction (P=0.01). In HT-DCM, the 5-year mortality rate was 26%. Univariate analyses selected age and creatinine for being positively related to mortality, and body mass index, FS and blood pressure during follow-up for being negatively related to mortality. Neither the improvement of left ventricular FS nor the decrease in left ventricular mass index was related to survival. Multivariate analysis identified (hazard ratio; 95% confidence interval) age (1.08; 1.02–1.13), body mass index (0.86; 0.75–0.98), and baseline FS (0.88; 0.78–0.98) as independent predictors of mortality. In conclusion, poor survival in HT-DCM can be anticipated by the severity of left ventricular systolic dysfunction and advanced age. Instead of ominous signs, high blood pressure and body mass may predict a more favourable prognosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kannel WB . Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75: 4–11.

    Article  CAS  PubMed  Google Scholar 

  2. Casale PN et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–178.

    Article  CAS  PubMed  Google Scholar 

  3. Kannel WB . Vital epidemiologic clues in heart failure. J Clin Epidemiol 2000; 53: 229–235.

    Article  CAS  PubMed  Google Scholar 

  4. Felker GM et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077–1084.

    Article  CAS  PubMed  Google Scholar 

  5. Alla F et al. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J 2000; 139: 895–904.

    Article  CAS  PubMed  Google Scholar 

  6. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 1967; 202: 1028–1034.

  7. Moser M, Hebert PR . Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214–1218.

    Article  CAS  PubMed  Google Scholar 

  8. Sahn DJ, DeMaria A, Kisslo J, Weyman A . The commitee on M-mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  PubMed  Google Scholar 

  9. Troy BL, Pombo J, Rackley CE . Measurement of left ventricular wall stress and mass by echocardiography. Circulation 1972; 45: 602–611.

    Article  CAS  PubMed  Google Scholar 

  10. Fortuin NJ, Hood Jr WP, Craige E . Evaluation of left ventricular function by echocardiography. Circulation 1972; 46: 26–35.

    Article  CAS  PubMed  Google Scholar 

  11. Pombo JF, Troy BL, Russell Jr RO . Left ventricular volumes and ejection fraction by echocardiography. Circulation 1971; 43: 480–490.

    Article  CAS  PubMed  Google Scholar 

  12. Levy D et al. The progression of hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.

    Article  CAS  PubMed  Google Scholar 

  13. Anguita M et al. [Heart failure caused by severe systolic ventricular dysfunction of hypertensive origin. Long-term clinical and functional course]. Rev Esp Cardiol 2000; 53: 927–931.

    Article  CAS  PubMed  Google Scholar 

  14. Brown DW, Giles WH, Croft JB . Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000; 140: 848–856.

    Article  CAS  PubMed  Google Scholar 

  15. Sundstrom J et al. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346–2351.

    Article  CAS  PubMed  Google Scholar 

  16. Frimm CD et al. Left ventricular hypertrophy predicts outcome of hypertension regardless of the type of ventricular arrhythmia present. J Hum Hypertens 1999; 13: 617–623.

    Article  CAS  PubMed  Google Scholar 

  17. Frimm CD et al. Normalization of left ventricular dysfunction in systemic hypertension. Clin Cardiol 2000; 23: 443–448.

    Article  Google Scholar 

  18. Cohn JN et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–310.

    Article  CAS  PubMed  Google Scholar 

  19. Lechat P et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation 1997; 96: 2197–2205.

    Article  CAS  PubMed  Google Scholar 

  20. Yurenev AP et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992; 5: 182S–189S.

    Article  CAS  PubMed  Google Scholar 

  21. Verdecchia P et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48–54.

    Article  CAS  PubMed  Google Scholar 

  22. Cipriano C et al. Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients. Am J Hypertens 2001; 14: 524–529.

    Article  CAS  PubMed  Google Scholar 

  23. Kenchaiah S et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–313.

    Article  PubMed  Google Scholar 

  24. Stevens J et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1–7.

    Article  CAS  PubMed  Google Scholar 

  25. Dwyer EM, Asif M, Ippolito T, Gillespie M . Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries. Am Heart J 2000; 139: 297–304.

    Article  CAS  PubMed  Google Scholar 

  26. Blake J et al. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med 1990; 88: 477–485.

    Article  CAS  PubMed  Google Scholar 

  27. Pascual M et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 2003; 89: 1152–1156.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Davos CH et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 29–35.

    Article  PubMed  Google Scholar 

  29. Anker SD et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361: 1077–1083.

    Article  CAS  PubMed  Google Scholar 

  30. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC . Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43: 1439–1444.

    Article  PubMed  Google Scholar 

  31. Juilliere Y et al. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol 1988; 21: 269–277.

    Article  CAS  PubMed  Google Scholar 

  32. Marmor A, Schneeweiss A . Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 1997; 29: 422–428.

    Article  CAS  PubMed  Google Scholar 

  33. Philbin EF et al. Race-related differences among patients with left ventricular dysfunction: observations from a biracial angiographic cohort. Harlem-Bassett LP(A) Investigators. J Card Fail 2000; 6: 187–193.

    Article  CAS  PubMed  Google Scholar 

  34. Frohlich ED . The sixth report of the Joint National Committee: an appropriate celebration of the 25th anniversary of the National High Blood Pressure Education Program. Hypertension 1997; 30: 1305–1306.

    CAS  PubMed  Google Scholar 

  35. Yancy CW, Laskar S, Eichhorn E . The use of beta-adrenergic receptor antagonists in the treatment of African Americans with heart failure. Congest Heart Fail 2004; 10: 34–37.

    Article  CAS  PubMed  Google Scholar 

  36. Badano LP et al. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. J Am Soc Echocardiogr 2004; 17: 253–261.

    Article  PubMed  Google Scholar 

  37. Philbin EF et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000; 109: 605–613.

    Article  CAS  PubMed  Google Scholar 

  38. Morales FJ et al. Deceleration time of early filling in patients with left ventricular systolic dysfunction: functional and prognostic independent value. Am Heart J 2002; 143: 1101–1106.

    Article  PubMed  Google Scholar 

  39. Hansen A et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 2001; 37: 1049–1055.

    Article  CAS  PubMed  Google Scholar 

  40. Dini FL et al. Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 85: 1455–1460.

    Article  CAS  PubMed  Google Scholar 

  41. Yamamoto T et al. Prognostic value of the atrial systolic mitral annular motion velocity in patients with left ventricular systolic dysfunction. J Am Soc Echocardiogr 2003; 16: 333–339.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clínica Médica-Emergências Clínicas, Hospital das Clínicas-Faculdade de Medicina da USP, São Paulo, SP, Brazil

    C de Carvalho Frimm, H N Soufen, M K Koike, V F A Pereira & M Cúri

Authors
  1. C de Carvalho Frimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H N Soufen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M K Koike
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V F A Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Cúri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C de Carvalho Frimm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Carvalho Frimm, C., Soufen, H., Koike, M. et al. The long-term outcome of patients with hypertensive cardiomyopathy. J Hum Hypertens 19, 393–400 (2005). https://doi.org/10.1038/sj.jhh.1001836

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001836

Keywords

This article is cited by

Search

Advanced search

Quick links